These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 7569583

  • 1. [New pharmacological approaches: rhDNase].
    Tournier G, Sardet A, Grosskopf C, Baculard A, Delaisi B.
    Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
    [Abstract] [Full Text] [Related]

  • 2. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 3. Where we are now with rhDNase.
    Geddes DM, Shah PL.
    Lancet; 1999 May 22; 353(9166):1727. PubMed ID: 10347981
    [No Abstract] [Full Text] [Related]

  • 4. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr 15; 36(920):34-5. PubMed ID: 8145672
    [No Abstract] [Full Text] [Related]

  • 5. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S.
    Chest; 1995 Feb 15; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [Abstract] [Full Text] [Related]

  • 6. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME.
    Am J Respir Crit Care Med; 1995 Mar 15; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [Abstract] [Full Text] [Related]

  • 7. Pulmozyme--Dornase alfa.
    Gutteridge C, Kuhn RJ.
    Pediatr Nurs; 1994 Mar 15; 20(3):278-9. PubMed ID: 8008477
    [Abstract] [Full Text] [Related]

  • 8. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec 15; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 9. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
    Bates RD, Nahata MC.
    J Clin Pharm Ther; 1995 Dec 15; 20(6):313-5. PubMed ID: 8847368
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement].
    Hodson M.
    Arch Pediatr; 1995 Jul 15; 2(7):679-81. PubMed ID: 7663660
    [Abstract] [Full Text] [Related]

  • 14. Dornase alfa: a new option in the management of cystic fibrosis.
    Witt DM, Anderson L.
    Pharmacotherapy; 1996 Jul 15; 16(1):40-8. PubMed ID: 8700791
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL.
    J Pediatr; 2001 Dec 15; 139(6):768-70. PubMed ID: 11743499
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.
    Fiel SB, Fuchs HJ, Johnson C, Gonda I, Clark AR.
    Chest; 1995 Jul 15; 108(1):153-6. PubMed ID: 7606951
    [Abstract] [Full Text] [Related]

  • 19. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G, Hoffjan S, Mosler K, Schuster A.
    Lung; 2001 Jul 15; 179(3):185-94. PubMed ID: 11891608
    [Abstract] [Full Text] [Related]

  • 20. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
    Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C.
    Lancet; 2001 Oct 20; 358(9290):1316-21. PubMed ID: 11684212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.